03:19 AM EDT, 09/05/2025 (MT Newswires) -- Joseph Klein III, Director, on September 03, 2025, sold 28,000 shares in Ionis Pharmaceuticals ( IONS ) for $1,680,000. Following the Form 4 filing with the SEC, Klein has control over a total of 16,446 common shares of the company, with 16,346 shares held directly and 100 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874015/000087401525000219/xslF345X05/edgardoc.xml